Adalimumab BS subcutaneous injection 80mg syringe 0.8mL “MA”, manufactured by Mochida Pharmaceutical, contains Adalimumab (genetical recombination) [Adalimumab follow-on 3]. Adalimumab is a TNF inhibitor used to treat autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. It is available as an 80mg/0.8mL/1 tube injectable drug (YJ code: 3999463G3028).
Adalimumab BS subcutaneous injection 80mg syringe 0.8mL “MA”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →